UnitedHealth Group, US91324P1021

UnitedHealth Group stock gains as analysts back 2026 earnings guidance

Published on 09/03/2026 at 15:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UnitedHealth Group stock is trading just below 400 USD as investors weigh strong Q2 2026 earnings, a tightened earnings guidance range and a supportive analyst consensus for the rest of the year.

Schwarz-Weiß-Reportage: Arzt in Telemedizin-Beratung per Laptop mit Patientin auf Bildschirm
UnitedHealth Group US91324P1021 zeigt Arzt bei digitaler Telemedizin-Konsultation per Laptop in Schwarz-Weiß, Illustration mit AI erstellt.

UnitedHealth Group stock (ISIN US91324P1021) is trading close to the 400 USD mark, with a latest closing price of 399.67 USD on the New York Stock Exchange as of September 2, 2026, according to market data compiled by MarketBeat.

Strong Q2 2026 earnings underpin the share

According to an instant alert overview on MarketBeat dated September 3, 2026, UnitedHealth Group reported earnings per share of 6.38 USD for its most recent quarter, beating analysts' consensus estimates of 4.94 USD by 1.44 USD.

The same MarketBeat summary notes that UnitedHealth Group has set its fiscal year 2026 guidance for adjusted earnings per share in a range of 19.50 to 20.00 USD, with sell side analysts on average forecasting 19.82 USD for the year.

Guidance, valuation and analyst view

MarketBeat data indicate that at a share price of about 399.67 USD as of September 2, 2026, UnitedHealth Group stock is trading on roughly 20 times the midpoint of the 2026 adjusted EPS guidance of 19.75 USD, a valuation level many investors consider supported by the company's earnings momentum.

According to the latest consensus overview on MarketBeat, UnitedHealth Group currently carries a Moderate Buy rating, with two Strong Buy recommendations, nineteen Buy ratings and six Hold ratings and an average target price of 456.56 USD.

Go deeper

More background on UnitedHealth Group

Investors can find additional news and filings on UnitedHealth Group and follow further developments around its 2026 guidance and analyst assessments.

Operational initiatives support sentiment

A separate analysis on Yahoo Finance dated September 2, 2026 highlights that UnitedHealth Group shares moved about 0.8% higher to 399.40 USD as investors reacted to plans to remove approximately 30% of prior authorization requirements in parts of its UnitedHealthcare business.

The same article points out that at a share price of 399.405 USD, UnitedHealth Group trades 32.59% below a GF Value estimate of 592.48 USD, suggesting upside potential in the eyes of some valuation models.

Representative product and customer reach

Beyond the numbers, UnitedHealth Group's breadth of services in health insurance and managed care continues to be a key pillar of its business model, with the UnitedHealthcare brand serving employer plans, individual policies and Medicare and Medicaid customers in the United States.

Stock price snapshot

Based on the latest available closing data on MarketBeat as of September 2, 2026, UnitedHealth Group stock closed at 399.67 USD on the New York Stock Exchange, giving the company a market capitalization of approximately 358.74 billion USD at that date.

UnitedHealth Group at a glance

  • Company: UnitedHealth Group Inc.
  • ISIN: US91324P1021
  • Ticker: UNH
  • Trading venue: New York Stock Exchange
  • Price (as of September 2, 2026): 399.67 USD
  • Market capitalization: 358.74 billion USD (as of September 2, 2026)
  • Sector / Industry: Health Care / Managed Care
  • Index membership: Dow Jones Industrial Average

Discover more on social platforms

Disclaimer...

en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 70049439 | bgmi